{"id":"W1572876072","doi":"10.1002/cncr.27582","title":"Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor–associated tumors","year":2012,"lang":"en","type":"article","venue":"Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Neutropenia; Internal medicine; Oncology; Adverse effect; Gastroenterology; Clinical endpoint; Microphthalmia-associated transcription factor; Surgery; Clinical trial; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006025996,0.0004704171,0.0007541782,0.0001522427,0.0001553429,0.0003310068,0.0002392099,0.0003670791,0.001040638],"category_scores_gemma":[0.0004628126,0.0001888329,0.0003840756,0.000189428,0.0001911535,0.0003073798,0.0001279723,0.0008107291,0.0002360491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003475803,"about_ca_system_score_gemma":0.0005032221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003529172,"about_ca_topic_score_gemma":0.001185658,"domain_scores_codex":[0.9998569,0.00007002013,0.00001243212,0.00001877692,0.0000145387,0.000027327],"domain_scores_gemma":[0.9997482,0.00006691538,0.00007324664,0.00000920624,0.00001657673,0.00008579684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3773938,0.01172691,0.05908517,0.001826024,0.002191382,0.00127668,0.0005383143,0.004754496,0.1330144,0.0004438077,0.007137151,0.4006119],"study_design_scores_gemma":[0.3014067,0.5321078,0.1245283,0.0001804649,0.001791929,0.003717577,0.0002229395,0.006266503,0.01636769,0.0003546373,0.01299515,0.0000602719],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924414,0.005891678,0.0002182175,0.0001884472,0.0000365368,0.0001833719,0.000164913,0.00003372836,0.0008418046],"genre_scores_gemma":[0.9971663,0.001597835,0.000316491,0.0001956677,0.00006543349,0.0001138125,0.0002642551,0.000004884386,0.0002754036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001040638,"threshold_uncertainty_score":0.003481269,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0182057423852344,"score_gpt":0.2572227953645037,"score_spread":0.2390170529792693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}